TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities

Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors

(2015) Sebastian Schölch et al.   Oncotarget

A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models

(2014) Amy L. Adlard et al.   INTERNATIONAL JOURNAL OF CANCER

Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy

(2013) Felix Klug et al.   CANCER CELL

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial

(2013) Fiona Bath-Hextall et al.   LANCET ONCOLOGY

Trial Watch

(2013) Erika Vacchelli et al.   OncoImmunology

Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma

(2012) S. J. Dovedi et al.   BLOOD

Antiviral applications of Toll-like receptor agonists

(2012) N. J. Horscroft et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Abscopal but desirable

(2012) Guido Kroemer et al.   OncoImmunology